*|MC_PREVIEW_TEXT|*

Ultrasound and DBT Screening, USPSTF Meeting Miss, and Ghost X-Ray
July 20, 2026
site logo

Together with

partner logo

“The modest cancer detection rate of 1 per 1000 screens, coupled with the disproportionate false-positive and biopsy burden observed in our cohort, suggests that density-based ultrasound screening in the DBT era casts too wide a net with too little yield.”

Dodelzon K et al, in a new study on supplemental ultrasound for breast screening with 2D mammography.

Sunday’s World Cup championship was tension-filled battle between two titans of the sport. Congratulations to Spain and their partisans for the victory. Looking forward to seeing if La Roja can run it back in 2030! – Brian Casey, Managing Editor

Imaging Wire Sponsors

AGFA HealthCare  •  Altamont Software  •  CARPL.ai  •  DeepHealth  •  Enlitic  •  Fujifilm  •  GE HealthCare  •  Intelerad  •  Kailo Medical  •  Mach7 Technologies  •  Medality  •  Medicom  •  Merge by Merative  •  Mosaic Clinical Technologies  •  Philips  •  Quibim  •  Rad AI  •  Riverain Technologies  •  Scanslated  •  Sectra  •  Siemens Healthineers  •  United Imaging  •  Us2.ai  •  Visage Imaging

Breast Imaging

Ultrasound and DBT Screening — Time to Call It Quits?

Ultrasound long ago carved out a role in breast cancer screening as a complementary tool to conventional 2D mammography. But is ultrasound still needed, now that U.S. breast screening programs have largely switched over to 3D digital breast tomosynthesis (DBT)? A new study in Academic Radiology raises questions. 

Conventional 2D mammography has well-known shortcomings, particularly in women with dense breast tissue that can obscure lesions. So alternative modalities like ultrasound, breast MRI, and contrast-enhanced mammography (CEM) are called in to help when needed.

  • Past research has shown that supplemental ultrasound can improve the cancer detection rate (CDR) in a 2D mammography screening program by 3-4 cancers per 1k women. 

But those studies were performed before the switch to DBT, which can often see around overlapping structures thanks to a gantry head that acquires multiple images as it pans across the breast. 

  • So is ultrasound still needed in screening programs using DBT? Researchers from Weill Cornell Medicine at New York-Presbyterian Hospital tested the hypothesis by examining 103k screening exams from 2014 to 2024 in which both DBT and ultrasound were used. 

In the study, researchers found that screening ultrasound after a negative DBT result…

  • Generated 1.9k biopsies, or 19 biopsies for every cancer the modality detected.
  • Produced an additional cancer detection rate of 1.0 per 1k women, compared to an additional CDR of 3-4 cancers for ultrasound in the 2D mammography era. 
  • Had an overall false-positive screening rate of 98.5%, a false-positive biopsy rate of 94.8%, and a positive predictive value of biopsies performed (PPV3) of just 5.2%.
  • Generated $652k false-positive screening ultrasound costs and $1.16M in ultrasound-guided biopsy costs.

The numbers are sobering and indicate that the days of ultrasound as a supplemental screening modality to DBT screening could be coming to a close. 

  • Instead, the researchers recommended that ultrasound screening be replaced by more sensitive modalities like breast MRI or CEM, both of which are fortunately more available now than during the 2D mammography era.

The Takeaway

The new study answers the question – in the negative – of whether supplementary ultrasound is still needed in the era of DBT screening. The positive subtext here is that the research confirms the improved detection performance of 3D compared to 2D mammography.

Purpose-Built for Modern Radiology

MosaicOS from Mosaic Clinical Technologies unites clinical expertise, AI, and advanced workflow tools in one intuitive platform. Find out how it can expand your clinical capacity and speed up turnaround times today.

sponsor logo

From Image Exchange to Enterprise Interoperability

Easily share, access, and exchange any medical image with solutions from Medicom. Deliver critical studies directly into the EHR to ease clinician burden, simplify your tech stack, and unlock the research potential hidden in clinical imaging data.

sponsor logo

How to Choose Between Tableside and Remote Fluoroscopy

Need help deciding whether tableside or universal remote fluoroscopy is right for you? This whitepaper from Siemens Healthineers may be able to put things in perspective.

sponsor logo

The Wire

  • USPSTF Misses Fourth Meeting: The USPSTF has again delayed its next meeting, originally scheduled for this month, extending its meeting gap to 16 months. The group’s decisions help guide clinical practice for screening tests like mammography and have the power to determine insurance reimbursement. While the USPSTF typically issues 20-25 decisions a year, the group has remained silent in 2026’s first half. HHS Secretary Robert F. Kennedy, Jr. cancelled the previous three meetings and removed both panel chairs in May, leaving many concerned about the task force’s future.
  • ‘Ghost Imaging’ Could Slash X-Ray Radiation: An experimental technique dubbed “ghost imaging” could cut radiation dose dramatically. In a paper in Optica, researchers from China demonstrated ghost imaging using two X-ray beams: a strong beam, used as a reference, that doesn’t pass through the object being imaged, and a weaker beam that does. Along with technologies like X-ray crystal splitting and optimized digital detectors, they acquired test images with 0.5% of the photons typically required. More tests are needed before ghost imaging can be used clinically.
  • Disparities in Lung Screening Outreach: A JAMA Network Open paper revealed socioeconomic disparities in how women responded to outreach efforts for CT lung cancer screening. Data from 34.6k Swedish women found that women were 71% more likely to respond to an eligibility questionnaire if they were more educated and 72% more likely if they had higher income. The good news is that once eligible women were identified, there was no difference in actual screening attendance. But outreach efforts may need to be tailored to ensure equal access. 
  • Lung Nodule AI Is Getting Better: As Europe implements large-scale CT lung cancer screening programs, is AI ready to help? A new literature review in European Radiology suggests it is, finding that over the last 12 years, the scientific evidence supporting AI for working up suspicious pulmonary nodules is becoming more sophisticated. The number of studies on nodule AI grew from 2012 to 2024 (from 14 to 95), and the percentage focusing on malignancy prediction also rose (from 6.7% to 29%).
  • 4DMedical Backs Lung Imaging Bill: Legislation introduced into the U.S. House of Representatives to establish a pilot program for functional lung imaging is drawing support from 4DMedical. Called the AIRCARE for Vets Act (H.R. 9666), the bill would direct the VA to explore 4D functional lung imaging to find respiratory disorders and lung diseases in military veterans. Veterans experience higher rates of lung diseases, often connected with their service, and 4DMedical has focused its lung imaging technology on these individuals. 
  • Deep Learning-Based CT Reconstruction: Canon Medical Systems continues to gain clinical traction for its Precise IQ Engine (PIQE) deep-learning CT reconstruction algorithm. In a new study in AJR, researchers in China compared PIQE to conventional hybrid iterative reconstruction for visualizing stents on 320-detector-row CT images of 73 patients. PIQE had better accuracy in multiple categories, including 31% better stent contrast to noise and 112% better edge sharpness. Radiologists also preferred the image quality of PIQE images and had greater diagnostic confidence. 
  • Is AI a Bad Influence? A new Radiology paper suggests it could be, especially when the AI is wrong. First, a group of 10 radiologists read 60 screening mammograms without AI. Six weeks later, the same group read the mammograms again with AI prompts, 28 of which were false negatives or false positives. The incorrect AI suggestions had a huge impact: false-negative suggestions resulted in a 32-percentage-point decrease in sensitivity. False-positive prompts actually gave a 17-point boost to specificity, but more prompts also increased read times. 
  • Industry Payments Linked to Device Use: Physicians who got payments from device vendors had higher utilization rates for devices from those companies. A new study in JAMA Network Open tracked the trend, which followed industry payments for 12 devices (none were imaging-related) from 2015 to 2023. Device payments totaled $136M, and doctors getting payments used devices at up to 4X the rate of physicians who weren’t paid. The disparity in use rates was typically greatest at the highest level of payments (over $10k per physician). 
  • New GE Partnerships: GE HealthCare has signed a pair of new partnerships with healthcare providers and academic centers. The company last week announced a 10-year contract to supply $500M in medical equipment, including imaging systems, to Catholic Health, a Long Island-based health system. In a second agreement, GE expanded its existing collaboration with Mayo Clinic to launch the MI-BET study, which aims to develop personalized radioligand therapy for prostate cancer patients. MI-BET will investigate whether imaging and biomarkers can drive more personalized theranostics treatments.
  • Woven Radiation Shields: Amid renewed focus on cath lab radiation dose, results in JSCAI show Texray’s MasterPeace textile radiation shields dramatically slashed occupational exposure versus conventional shields. Across 190 randomized procedures, first operators and scrub nurses saw exposure fall by 78% and 77%, respectively, when using the lead-free table drapes and over-the-patient patches. Aprons were worn in all cases, though with MasterPeace and other advances in radiation safety, ditching this burdensome gear might soon be possible.
  • Enlitic Lands Lumus Contract: Data management software firm Enlitic signed a three-year contract to provide its Ensight solutions to Lumus Imaging, an imaging services provider in Australia. Lumus will deploy Ensight to standardize hanging protocols, perform deidentification of patient data, and validate AI algorithms. The contract is valued at $248,000 and is Enlitic’s first Ensight subscription in the country as well as its second deployment through its Intelerad OEM channel. 
  • Bunkerhill Raises $25M: Bunkerhill’s ascent continues with a $25M Series B funding round, bringing its lifetime funding to $55M. The raise will help grow the company’s Carebricks agentic AI platform, which has already amassed an impressive client list with names like Cleveland Clinic and Intermountain Health. In March, the FDA cleared a pair of Bunkerhill’s AI solutions for calculating coronary and aortic valve calcium using contrast CT, bringing the number of risk detection and diagnostic algorithms embedded into Carebricks to nine. 
  • Healthcare Spending Soars: CMS found that U.S. healthcare spending rose 7.3% last year to $5.7T, continuing the trend seen in 2023 and 2024. The surge stems from sky-high care utilization and drug spending, especially on GLP-1s. The report anticipates a slowdown throughout 2026, with declining ACA and Medicaid enrollment throwing a wet towel on the spending frenzy. Americans are nonetheless on pace for $9T in healthcare spending by 2034, outstripping GDP growth and making the sector even more central to the U.S. economy.
  • Raidium Debuts Oncology Viewer: Just a few weeks after introducing a vision-language model for CT scans, French startup Raidium debuted Raidium Read (R.Read), an AI-native viewer for oncology images. R.Read is designed to simplify workflow for oncology image review and follow-up, with tools for longitudinal tracking and referring physician communication. The viewer is available now for oncology research and is pending FDA clearance for broader clinical use. It has already been deployed at Moffitt Cancer Center in Florida.

A New Solution for Radiology Reporting

Sectra Reporting delivers a fully built-in, AI-enhanced reporting experience that seamlessly connects PACS imaging data and measurements through intuitive templates. Discover how it can meet your needs today.

sponsor logo

Transform Imaging Data into Actionable Predictions

When you choose Quibim, you get more than a partner for detecting and diagnosing prostate cancer on MRI scans. Learn how they can help you transform imaging data into actionable predictions by booking a demo today.

sponsor logo

Radiology Automation Simplified

CARPL is an enterprise-grade radiology AI validation and deployment platform with 250+ AI applications across 85+ AI vendors that empowers healthcare providers to access, assess, and securely integrate imaging AI in their practice. Book a demo today.

sponsor logo

The Resource Wire

  • KailoFlow Replaces the Patchwork: KailoFlow from Kailo Medical gives you one platform from digital patient intake to final structured report, with automated measurement transfer, built-in TI-RADS and BI-RADS calculations, and pre-drafted reporting across any device, any site.
  • Smoothing the Transition to Radiology Integration: Consolidation among medical imaging providers is creating challenges when it comes to managing and integrating image data from diverse sources. In this edition of The Imaging Wire Show, we discussed how solutions from Enlitic can smooth the transition. 
  • AI Echo in Community Heart Failure Screening: Breathlessness affects 10% of the adult population and can be a symptom of heart failure. Learn how a community-based program in the U.K. is using AI-assisted echocardiography from Us2.ai to achieve guideline-directed diagnostic quality in a community setting.  
  • Your Workflow is Outgrowing Your Reporting Software: Stop fighting your reporting platform. Reduce clicks, improve report quality, and work naturally with solutions from Rad AI – AI built around radiologists, not legacy workflows. Book a demo.
  • Radiology Without Limits: Watch this video from Visage Imaging to learn how their Visage 7 solution enables you to achieve radiology without limits – performance, reliability, and innovation. 
  • Innovation for the Imaging Workflows You Deserve: Radiologists are overwhelmed by complex systems and growing caseloads. Workflow orchestration offers a smarter approach. Find out how solutions from Merge can integrate various PACS, RIS, and EMR systems into a single AI-driven workspace. 
  • Elevating Outpatient Imaging in Texas: River Oaks MRI & Diagnostic in Texas was founded on a simple but powerful idea: to bring high-quality, accessible imaging to the local community. Learn how they turned to United Imaging to help realize their vision. 
  • A Best in KLAS Hat Trick: AGFA HealthCare was named Best in KLAS in three enterprise imaging segments this year: PACS under 300k studies, universal viewer, and vendor-neutral archive. Find out what makes customers keep coming back on this page.
  • Reimbursement for AI-Powered CAC Scoring: Medicare reimbursement for AI-powered coronary artery calcium scoring is now available with code G0680. Find out how it can impact your practice – and your patients – in this video interview with Riverain Technologies. 
  • 3T Wide-Bore MRI Delivers Power with Purpose: Translate groundbreaking discoveries into patient care with SIGNA Bolt, GE HealthCare’s visionary 3T MRI scanner that empowers leading-edge research for real patient care. 
  • Providing the Best CT for Patients – with Confidence: Nashville General Hospital is an essential hospital, but they are determined to invest in CT technology that enables them to compete with larger facilities. Learn how they turned to Fujifilm’s Scenaria View CT scanner to accomplish both goals.  
  • Would You Trust a Chatbot to Educate Your Patients? Scanslated provides patient education powered by real human intelligence – not AI. Scanslated’s interactive reports use unique, patient-centered explanations written by board-certified physicians specifically for a patient audience. Learn how Scanslated can benefit your patients today. 
  • Preserve Your Radiography Investment: FutureProof 20 is Philips’ commitment to support their Radiography 7300 C for 20 years, helping you keep the system performing for decades, reducing total cost of ownership over the long run and letting you focus on the patient.  
  • IT Solutions for Radiologist Efficiency: Inefficiencies in reporting are some of the biggest challenges facing radiologists today. Learn how imaging IT solutions from Altamont Software can help radiologists work more efficiently in this Imaging Wire Show video.
  • AI-Powered Population Health: DeepHealth is assembling radiology’s largest portfolio of AI-enabled radiology solutions for population health. Learn more about their focus and their recent acquisition of Gleamer in this video interview. 
  • What Everyone Should Know About Radiology: What should every medical student know about radiology? In this episode of The Joys of Radiology, a Medality Radiology Report podcast, Gautam Agrawal, MD, sits down with three Johns Hopkins radiology residents to discuss what residency actually looks like.
  • How Cloud-Based Enterprise Imaging Accelerates Insights: Cloud-based enterprise imaging shortens the path from scan to diagnosis by centralizing data, automating workflows, and enabling AI-driven prioritization. Find out how Intelerad’s cloud-native imaging platform can help you change healthcare delivery. 
  • Legacy Imaging Systems Create Friction: Simplify imaging access, reduce complexity, and support enterprise imaging growth with solutions from Mach7 Technologies.

The Industry Wire

  1. Biopharma firms ride high into Q2 earnings season. 
  2. UnitedHealthcare beats expectations with Q2 financials. 
  3. Are payors backing away from pledges to reform prior authorization? 
  4. U.S. Senate votes to save WISeR prior auth pilot project.
  5. Hospitals look for help to automate RCM processes. 
  6. FDA officials retreat from policy guidelines from previous officials. 
  7. Is data on ultrasound-directed gene therapy “too good to be true?”
  8. Deaths from coronary artery disease fall in U.S. 
  9. Editors at diabetes journal rebel after claiming censorship. 
  10. California farm linked to cyclosporiasis outbreak preps wider recall.